DK0714307T3 - Vaccinesammensætninger - Google Patents

Vaccinesammensætninger

Info

Publication number
DK0714307T3
DK0714307T3 DK94921761T DK94921761T DK0714307T3 DK 0714307 T3 DK0714307 T3 DK 0714307T3 DK 94921761 T DK94921761 T DK 94921761T DK 94921761 T DK94921761 T DK 94921761T DK 0714307 T3 DK0714307 T3 DK 0714307T3
Authority
DK
Denmark
Prior art keywords
pct
date feb
sec
vaccine composition
hepatitis
Prior art date
Application number
DK94921761T
Other languages
English (en)
Inventor
Mark Roberts
Steven Chatfield
Original Assignee
Medeva Holdings Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medeva Holdings Bv filed Critical Medeva Holdings Bv
Application granted granted Critical
Publication of DK0714307T3 publication Critical patent/DK0714307T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
    • C12N2770/32422—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
    • C12N2770/32434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
DK94921761T 1993-08-12 1994-07-29 Vaccinesammensætninger DK0714307T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939316745A GB9316745D0 (en) 1993-08-12 1993-08-12 Vaccine compositions
PCT/GB1994/001646 WO1995005194A1 (en) 1993-08-12 1994-07-29 Vaccine compositions

Publications (1)

Publication Number Publication Date
DK0714307T3 true DK0714307T3 (da) 2000-04-10

Family

ID=10740372

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94921761T DK0714307T3 (da) 1993-08-12 1994-07-29 Vaccinesammensætninger

Country Status (12)

Country Link
US (2) US6129922A (da)
EP (1) EP0714307B1 (da)
JP (1) JP3883203B2 (da)
KR (1) KR100341958B1 (da)
AT (1) ATE185073T1 (da)
AU (1) AU674983B2 (da)
DE (1) DE69420970T2 (da)
DK (1) DK0714307T3 (da)
ES (1) ES2139083T3 (da)
GB (1) GB9316745D0 (da)
GR (1) GR3032134T3 (da)
WO (1) WO1995005194A1 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9316745D0 (en) * 1993-08-12 1993-09-29 Medeva Holdings Bv Vaccine compositions
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US6946117B1 (en) 1997-09-29 2005-09-20 Nektar Therapeutics Stabilized preparations for use in nebulizers
US6433040B1 (en) 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
EP1146906B1 (en) 1999-02-05 2011-07-06 Alk-Abelló A/S Mucosal delivery system
US7442388B2 (en) 2000-05-10 2008-10-28 Weers Jeffry G Phospholipid-based powders for drug delivery
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US20020051794A1 (en) 2000-08-09 2002-05-02 Alk-Abello A/S Novel parenteral vaccine formulations and uses thereof
CA2466982A1 (en) * 2001-11-19 2003-05-30 Becton, Dickinson And Company Pharmaceutical compositions in particulate form
US7368102B2 (en) 2001-12-19 2008-05-06 Nektar Therapeutics Pulmonary delivery of aminoglycosides
KR100748842B1 (ko) 2004-09-09 2007-08-13 주식회사한국야쿠르트 에이형 간염바이러스에 대한 항체 제조방법 및 그 응용

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0418626B1 (en) * 1989-09-08 1993-12-29 Takeda Chemical Industries, Ltd. Fused proteins and production thereof
JPH03135923A (ja) * 1989-10-20 1991-06-10 Chemo Sero Therapeut Res Inst 百日咳毒素ｂオリゴマーの構成サブユニットを含有する経鼻接種ワクチン
US5294548A (en) * 1990-04-02 1994-03-15 American Biogenetic Sciences, Inc Recombianant Hepatitis a virus
US5549896A (en) * 1991-05-08 1996-08-27 Schweiz. Serum- & Impfinstitut Bern Hepatitis a virus strain, method for the isolation of new hepatitis a virus strains and hepatitis a vaccines
DK17093D0 (da) * 1993-02-15 1993-02-15 Lyfjathroun H F Farmaceutisk praeparat til topisk administrering af antigener og/eller vacciner til pattedyr via slimhinder
GB9316745D0 (en) * 1993-08-12 1993-09-29 Medeva Holdings Bv Vaccine compositions
BR9506704A (pt) 1994-02-03 1997-09-09 Analogic Corp Aparelho e sistema de tomografia e processo de varredura de um objeto com um sistema de varredura topográfica
US5766906A (en) * 1994-07-11 1998-06-16 The University Of North Carolina At Chapel Hill Hepatitis A virus deletion mutants and vaccine formulations containing the same

Also Published As

Publication number Publication date
KR100341958B1 (ko) 2003-03-15
AU7235694A (en) 1995-03-14
US6129922A (en) 2000-10-10
DE69420970D1 (de) 1999-11-04
ATE185073T1 (de) 1999-10-15
WO1995005194A1 (en) 1995-02-23
AU674983B2 (en) 1997-01-16
DE69420970T2 (de) 2000-03-30
US6699480B2 (en) 2004-03-02
JP3883203B2 (ja) 2007-02-21
JPH09501437A (ja) 1997-02-10
EP0714307A1 (en) 1996-06-05
ES2139083T3 (es) 2000-02-01
GR3032134T3 (en) 2000-04-27
EP0714307B1 (en) 1999-09-29
GB9316745D0 (en) 1993-09-29
KR960703619A (ko) 1996-08-31
US20030007979A1 (en) 2003-01-09

Similar Documents

Publication Publication Date Title
GB9316745D0 (en) Vaccine compositions
FI944676A0 (fi) Rokotteita, jotka sisältävät ionisoitumattomia pinta-aktiivisten aineiden vesikkeleitä
ATE350057T1 (de) Impfstoffzusammesetzung
BR9814487A (pt) "vacina"
EP0090581A3 (en) Small peptides with the specificity of foot and mouth disease viral antigens
KR920004422A (ko) Hiv의 주요 중화 결정인자
ATE154244T1 (de) Induzierung eines schutzes gegen virale infektionen
CA2168885A1 (en) Vaccine compositions
KR100871455B1 (ko) Ｈｉｖ 바이러스에 대한 천연 항체
CA2388054A1 (en) Compositions and methods for stimulating an immune response against infectious agents
FR2646607B1 (fr) Anticorps monoclonaux anti-b2 microglobuline
DE68922540D1 (de) Vorläufer des Hüllenglykoproteins des HIV-2 Retrovirus und verwandte Antigene.
ATE204761T1 (de) Pharmazeutische antigen-/antikörperpräparation
DK1442124T3 (da) Polypeptidantigen, der danner en mimetisk struktur af gp41-mellemstanden